Larvol Delta - A-Multicenter-Randomized-Openlabel-Controlled-Study-of-HAIC-Combined-With-Camrelizumab-and-Apatinib-Mesylate-for-Perioperative-Treatment-of-Resectable-Hepatocellular-Carcinoma-With-Highrisk-Recurrence-Factors

oxaliplatin - Generic mfg.

AiTan (rivoceranib) - Elevar Therapeutics

5-fluorouracil - Generic mfg.

leucovorin calcium - Generic mfg.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07618546

Jun 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next